MovDisordV3, PascalFrancis, Corpus, bibRecord, 001701

Predicting the cost of Parkinson's disease

Identifieur interne : 001701 ( PascalFrancis/Corpus ); précédent : 001700; suivant : 001702

Predicting the cost of Parkinson's disease

Auteurs : Paul Mccrone ; Liesl M. Allcock ; David J. Burn

Source :

Movement disorders [ 0885-3185 ] ; 2007.

RBID : Pascal:07-0263056

Descripteurs français

Pascal (Inist)
- Système nerveux pathologie, Parkinson maladie, Coût, Analyse coût.

English descriptors

KwdEn :
- Cost analysis, Costs, Nervous system diseases, Parkinson disease.

Abstract

The degenerative nature of Parkinson's disease (PD) suggests that it will lead to high levels of resource use. This study measures service use and costs for a representative community sample of PD patients and identifies cost predictors. Patients were identified from general practices and were interviewed twice, separated by a 12-month interval. Demographic and clinical data on patients were collected and 6-month costs were calculated. Regression analysis was used to identify significant baseline predictors of follow-up costs. The annual service costs (baseline and follow-up combined) were £13,804 per person. Formal service costs accounted for 20% of this figure with informal care from families/friends accounting for 80%. The regression model explained 42% of total follow-up costs and significant predictors included gender (with men having higher costs), disability, and depression.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 22`
A06				`@2 6`
A08	`01`	`1`	`ENG`	`@1 Predicting the cost of Parkinson's disease`
A11	`01`	`1`		`@1 MCCRONE (Paul)`
A11	`02`	`1`		`@1 ALLCOCK (Liesl M.)`
A11	`03`	`1`		`@1 BURN (David J.)`
A14	`01`			`@1 King's College London, Centre for the Economics of Mental Health, Health Services Research Department, Institute of Psychiatry @2 London @3 GBR @Z 1 aut.`
A14	`02`			`@1 Institute for Ageing and Health, Newcastle University @2 Newcastle Upon Tyne @3 GBR @Z 2 aut. @Z 3 aut.`
A14	`03`			`@1 Department of Neurology, Royal Hospital @2 Sunderland @3 GBR @Z 2 aut. @Z 3 aut.`
A20				`@1 804-812`
A21				`@1 2007`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000149445250070`
A44				`@0 0000 @1 © 2007 INIST-CNRS. All rights reserved.`
A45				`@0 30 ref.`
A47	`01`	`1`		`@0 07-0263056`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 The degenerative nature of Parkinson's disease (PD) suggests that it will lead to high levels of resource use. This study measures service use and costs for a representative community sample of PD patients and identifies cost predictors. Patients were identified from general practices and were interviewed twice, separated by a 12-month interval. Demographic and clinical data on patients were collected and 6-month costs were calculated. Regression analysis was used to identify significant baseline predictors of follow-up costs. The annual service costs (baseline and follow-up combined) were £13,804 per person. Formal service costs accounted for 20% of this figure with informal care from families/friends accounting for 80%. The regression model explained 42% of total follow-up costs and significant predictors included gender (with men having higher costs), disability, and depression.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C02	`03`	`X`		`@0 002B17A03`
C03	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 01`
C03	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 01`
C03	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 01`
C03	`02`	`X`	`FRE`	`@0 Parkinson maladie @5 02`
C03	`02`	`X`	`ENG`	`@0 Parkinson disease @5 02`
C03	`02`	`X`	`SPA`	`@0 Parkinson enfermedad @5 02`
C03	`03`	`X`	`FRE`	`@0 Coût @5 09`
C03	`03`	`X`	`ENG`	`@0 Costs @5 09`
C03	`03`	`X`	`SPA`	`@0 Coste @5 09`
C03	`04`	`X`	`FRE`	`@0 Analyse coût @5 10`
C03	`04`	`X`	`ENG`	`@0 Cost analysis @5 10`
C03	`04`	`X`	`SPA`	`@0 Análisis costo @5 10`
C07	`01`	`X`	`FRE`	`@0 Encéphale pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
N21				`@1 176`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 07-0263056 INIST
ET :	Predicting the cost of Parkinson's disease
AU :	MCCRONE (Paul); ALLCOCK (Liesl M.); BURN (David J.)
AF :	King's College London, Centre for the Economics of Mental Health, Health Services Research Department, Institute of Psychiatry/London/Royaume-Uni (1 aut.); Institute for Ageing and Health, Newcastle University/Newcastle Upon Tyne/Royaume-Uni (2 aut., 3 aut.); Department of Neurology, Royal Hospital/Sunderland/Royaume-Uni (2 aut., 3 aut.)
DT :	Publication en série; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 6; Pp. 804-812; Bibl. 30 ref.
LA :	Anglais
EA :	The degenerative nature of Parkinson's disease (PD) suggests that it will lead to high levels of resource use. This study measures service use and costs for a representative community sample of PD patients and identifies cost predictors. Patients were identified from general practices and were interviewed twice, separated by a 12-month interval. Demographic and clinical data on patients were collected and 6-month costs were calculated. Regression analysis was used to identify significant baseline predictors of follow-up costs. The annual service costs (baseline and follow-up combined) were £13,804 per person. Formal service costs accounted for 20% of this figure with informal care from families/friends accounting for 80%. The regression model explained 42% of total follow-up costs and significant predictors included gender (with men having higher costs), disability, and depression.
CC :	002B17; 002B17G; 002B17A03
FD :	Système nerveux pathologie; Parkinson maladie; Coût; Analyse coût
FG :	Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie
ED :	Nervous system diseases; Parkinson disease; Costs; Cost analysis
EG :	Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease
SD :	Sistema nervioso patología; Parkinson enfermedad; Coste; Análisis costo
LO :	INIST-20953.354000149445250070
ID :	07-0263056

Links to Exploration step

Pascal:07-0263056

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Predicting the cost of Parkinson's disease</title>
<author><name sortKey="Mccrone, Paul" sort="Mccrone, Paul" uniqKey="Mccrone P" first="Paul" last="Mccrone">Paul Mccrone</name>
<affiliation><inist:fA14 i1="01"><s1>King's College London, Centre for the Economics of Mental Health, Health Services Research Department, Institute of Psychiatry</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Allcock, Liesl M" sort="Allcock, Liesl M" uniqKey="Allcock L" first="Liesl M." last="Allcock">Liesl M. Allcock</name>
<affiliation><inist:fA14 i1="02"><s1>Institute for Ageing and Health, Newcastle University</s1>
<s2>Newcastle Upon Tyne</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, Royal Hospital</s1>
<s2>Sunderland</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name>
<affiliation><inist:fA14 i1="02"><s1>Institute for Ageing and Health, Newcastle University</s1>
<s2>Newcastle Upon Tyne</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, Royal Hospital</s1>
<s2>Sunderland</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">07-0263056</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0263056 INIST</idno>
<idno type="RBID">Pascal:07-0263056</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001701</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Predicting the cost of Parkinson's disease</title>
<author><name sortKey="Mccrone, Paul" sort="Mccrone, Paul" uniqKey="Mccrone P" first="Paul" last="Mccrone">Paul Mccrone</name>
<affiliation><inist:fA14 i1="01"><s1>King's College London, Centre for the Economics of Mental Health, Health Services Research Department, Institute of Psychiatry</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Allcock, Liesl M" sort="Allcock, Liesl M" uniqKey="Allcock L" first="Liesl M." last="Allcock">Liesl M. Allcock</name>
<affiliation><inist:fA14 i1="02"><s1>Institute for Ageing and Health, Newcastle University</s1>
<s2>Newcastle Upon Tyne</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, Royal Hospital</s1>
<s2>Sunderland</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name>
<affiliation><inist:fA14 i1="02"><s1>Institute for Ageing and Health, Newcastle University</s1>
<s2>Newcastle Upon Tyne</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, Royal Hospital</s1>
<s2>Sunderland</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cost analysis</term>
<term>Costs</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Parkinson maladie</term>
<term>Coût</term>
<term>Analyse coût</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The degenerative nature of Parkinson's disease (PD) suggests that it will lead to high levels of resource use. This study measures service use and costs for a representative community sample of PD patients and identifies cost predictors. Patients were identified from general practices and were interviewed twice, separated by a 12-month interval. Demographic and clinical data on patients were collected and 6-month costs were calculated. Regression analysis was used to identify significant baseline predictors of follow-up costs. The annual service costs (baseline and follow-up combined) were £13,804 per person. Formal service costs accounted for 20% of this figure with informal care from families/friends accounting for 80%. The regression model explained 42% of total follow-up costs and significant predictors included gender (with men having higher costs), disability, and depression.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>22</s2>
</fA05>
<fA06><s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Predicting the cost of Parkinson's disease</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MCCRONE (Paul)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>ALLCOCK (Liesl M.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BURN (David J.)</s1>
</fA11>
<fA14 i1="01"><s1>King's College London, Centre for the Economics of Mental Health, Health Services Research Department, Institute of Psychiatry</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Institute for Ageing and Health, Newcastle University</s1>
<s2>Newcastle Upon Tyne</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurology, Royal Hospital</s1>
<s2>Sunderland</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s1>804-812</s1>
</fA20>
<fA21><s1>2007</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000149445250070</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>30 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>07-0263056</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The degenerative nature of Parkinson's disease (PD) suggests that it will lead to high levels of resource use. This study measures service use and costs for a representative community sample of PD patients and identifies cost predictors. Patients were identified from general practices and were interviewed twice, separated by a 12-month interval. Demographic and clinical data on patients were collected and 6-month costs were calculated. Regression analysis was used to identify significant baseline predictors of follow-up costs. The annual service costs (baseline and follow-up combined) were £13,804 per person. Formal service costs accounted for 20% of this figure with informal care from families/friends accounting for 80%. The regression model explained 42% of total follow-up costs and significant predictors included gender (with men having higher costs), disability, and depression.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B17A03</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Coût</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Costs</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Coste</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Analyse coût</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Cost analysis</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Análisis costo</s0>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>176</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 07-0263056 INIST</NO>
<ET>Predicting the cost of Parkinson's disease</ET>
<AU>MCCRONE (Paul); ALLCOCK (Liesl M.); BURN (David J.)</AU>
<AF>King's College London, Centre for the Economics of Mental Health, Health Services Research Department, Institute of Psychiatry/London/Royaume-Uni (1 aut.); Institute for Ageing and Health, Newcastle University/Newcastle Upon Tyne/Royaume-Uni (2 aut., 3 aut.); Department of Neurology, Royal Hospital/Sunderland/Royaume-Uni (2 aut., 3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 6; Pp. 804-812; Bibl. 30 ref.</SO>
<LA>Anglais</LA>
<EA>The degenerative nature of Parkinson's disease (PD) suggests that it will lead to high levels of resource use. This study measures service use and costs for a representative community sample of PD patients and identifies cost predictors. Patients were identified from general practices and were interviewed twice, separated by a 12-month interval. Demographic and clinical data on patients were collected and 6-month costs were calculated. Regression analysis was used to identify significant baseline predictors of follow-up costs. The annual service costs (baseline and follow-up combined) were £13,804 per person. Formal service costs accounted for 20% of this figure with informal care from families/friends accounting for 80%. The regression model explained 42% of total follow-up costs and significant predictors included gender (with men having higher costs), disability, and depression.</EA>
<CC>002B17; 002B17G; 002B17A03</CC>
<FD>Système nerveux pathologie; Parkinson maladie; Coût; Analyse coût</FD>
<FG>Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie</FG>
<ED>Nervous system diseases; Parkinson disease; Costs; Cost analysis</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease</EG>
<SD>Sistema nervioso patología; Parkinson enfermedad; Coste; Análisis costo</SD>
<LO>INIST-20953.354000149445250070</LO>
<ID>07-0263056</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001701 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001701 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:07-0263056
   |texte=   Predicting the cost of Parkinson's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Predicting the cost of Parkinson's disease

Predicting the cost of Parkinson's disease

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri